Product image of Yesintek (Ustekinumab) supplied by GNH India

Yesintek

Active Ingredient:
Ustekinumab
Origin:
EU

Yesintek (Ustekinumab)

Yesintek (ustekinumab) is a biologic therapy used for immune-mediated conditions. It works by modulating specific immune pathways to reduce inflammation. This EU-approved biosimilar offers an alternative to branded biologics for targeted treatment. Ideal for patients seeking cost-effective immune support.

Manufacturer / TM Owner

Biosimilar Collaborations Ireland Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Ustekinumab is commonly used to manage immune-related disorders such as moderate to severe plaque psoriasis and active psoriatic arthritis. It may also be prescribed for moderate to severe Crohn’s disease or ulcerative colitis in adults who have not responded to conventional therapies. Patients often ask, 'what is ustekinumab used for' when exploring treatment options for chronic inflammatory conditions.

Side Effects

  • This medication helps reduce symptoms like joint pain, skin plaques, and gastrointestinal discomfort by targeting specific proteins involved in inflammation. Users may notice gradual improvement in their condition over several weeks of consistent use. Individual responses can vary based on the underlying health issue being treated.

Precautions & Warnings

  • Store Yesintek in a refrigerator until ready for use, but avoid freezing. Keep the medication in its original packaging to protect it from light. Always check the solution for particles or discoloration before administration. Discard any unused portion as directed by a healthcare provider.

Avoid Interactions

  • Ustekinumab may interact with live vaccines, so avoid vaccination during treatment unless approved by a doctor. Caution is advised when combining with other immunosuppressants, as the effects on the immune system could be additive. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

Symptom improvement may take several weeks, with some patients noticing changes within 2–4 weeks of starting treatment.

Consult a healthcare provider to weigh potential risks and benefits, as the effects on pregnancy are not fully established.

Yes, Yesintek is a biosimilar to the reference biologic, offering a similar therapeutic effect at a potentially lower cost.

Dosage frequency typically ranges from every 12 weeks to every 8 weeks, depending on the condition being treated.

Contact your healthcare provider for guidance; do not take a double dose to make up for a missed one.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ustekinumab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT